Is Friedreich’s Ataxia Developmental or Degenerative?
Arnulf Koeppen, MD
Next-Generation MS Care: The Promise of Cell-Based Therapeutics
Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC
RAISE Subgroup Analysis: Zilucoplan Without Prior Rescue Therapy in gMG
BCMA mRNA CAR-T Shows Durable Benefit in MG
SPOTLIGHT Registry Findings on Eculizumab and Ravulizumab in gMG
FA hiPSCs in Translational Drug Development
Omaveloxolone in Friedreich’s Ataxia: Early Real-World Signals
Proactive Pregnancy Planning and Reproductive Care in MS
Riley Bove, MD, MMSc
Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
Aaron Miller, MD
Nutrition and the Gut-Brain Connection in Schizophrenia
Shelina Ramnarine, PhD
Deanna L. Kelly, PharmD, BCPP
Emerging Serum microRNAs as Early Signals in MS
Depression as a Signal of MS Progression
Advancing Pediatric MS Care: Insights from AAN 2026
Elizabeth Wilson, MD
Challenging the Status Quo in Schizophrenia Treatment
Stephen Marder, MD
Updates in MS Care: Key Topics at AAN 2026
The Social Brain in Schizophrenia
Michael Green, PhD
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.